Stay updated on PTI-801 Safety and Pharmacokinetics in CF Clinical Trial
Sign up to get notified when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.

Latest updates to the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page
- Check3 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of the trial structure and participant criteria for a study involving PTI-801, while retaining the mention of healthy volunteers and the revision number.SummaryDifference26%
- Check10 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check17 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check25 days agoNo Change Detected
- Check53 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check68 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check75 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to PTI-801 Safety and Pharmacokinetics in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.